Clemens van Blitterswijk

Last updated

Clemens van Blitterswijk
VanBlitterswijk.JPG
Clemens van Blitterswijk
Born1957 (age 6667)
The Hague, Netherlands
NationalityDutch
Alma mater University of Leiden
AwardsJean Leray Award;

The Marie Parijs Award; The Klein Award;

George Winter Award; Huibregtsen Prize; Career Achievement Award;
Scientific career
Fields Biomedical engineering, biomaterials, tissue engineering
Institutions University of Maastricht

Clemens A. van Blitterswijk (1957, The Hague) is a Dutch tissue engineer who contributed to the use of biomaterials to heal bone injuries, especially using osteoinductive ceramics. [1] [2] In collaboration with Jan de Boer and others, he has contributed to screening microtextures to study cell-biomaterial interactions, an approach termed materiomics.

Contents

Career

Blitterswijk graduated from a bachelor in cell biology at Leiden University and defended his PhD thesis in 1985 at the same university on artificial ceramic middle ear implants under the supervision of Professor Jan Grote [3] and Klaas de Groot, [4] for which he was awarded the Jean Leray young scientist award from the European Society for Biomaterials in 1987. [5] From 1985 to 1996, he worked on hydroxyapatite biomaterials for middle ear implants under the mentorship of Jan Grote [6] [7] [8] and Klaas De Groot [9] [10] at Leiden University.

In 1996, he left Leiden University and co-founded, together with Klaas De Groot, IsoTis BV, a life sciences company focused on bone biomaterials and tissue engineering.

In 1997, he became a professor at University of Twente. Later, he was appointed director of the University of Twente's MIRA Institute for Biomedical Technology and Technical Medicine institute (the institute no longer exists). In collaboration with Jan de Boer, Hemant Unadkat, and Dimitrios Stamatialis, he contributed to the development of a high-throughput assay to design and select micrometer-scale surface textures that could enhance specific biological functions (TopoChip). [11] [12]

In 2012, he became a partner of the Life Science Partner (LSP) private investment firm where he invests in private companies and startups related to healthcare innovations. [13]

In 2014, he became a distinguished professor at Maastricht University. [14] Until 2018, he was the director and department chair at the MERLN Institute at Maastricht University. In 2015, he was awarded an ERC Advanced grant that aimed at developing microfabricated and microfluidic cell culture platforms for improving organoids. [15] The conception of this grant application and the research relative to it were done by several principal investigators at Maastricht University. [16] [17] [18] [19] [20] [21]

Valorization

He has served as CEO of IsoTis., [22] a company that underwent an Initial Public Offering and was subsequently acquired by Integra LifeSciences. [23] [24] In 2018, he became the chairman of the board of directors of Kuros Biosciences. [25]

Teaching

Blitterswijk has been the official supervisor of over 80 PhD candidates who, in their large majority, have worked in the laboratories of other faculty members. He has participated as an editor of four textbooks, including one dedicated to tissue engineering. [26]

Awards

Ten outstanding publications as a co-author or corresponding author

Related Research Articles

<span class="mw-page-title-main">Ultrastructure</span> Detail hidden to optical microscopes

Ultrastructure is the architecture of cells and biomaterials that is visible at higher magnifications than found on a standard optical light microscope. This traditionally meant the resolution and magnification range of a conventional transmission electron microscope (TEM) when viewing biological specimens such as cells, tissue, or organs. Ultrastructure can also be viewed with scanning electron microscopy and super-resolution microscopy, although TEM is a standard histology technique for viewing ultrastructure. Such cellular structures as organelles, which allow the cell to function properly within its specified environment, can be examined at the ultrastructural level.

<span class="mw-page-title-main">Embryoid body</span> Three-dimensional aggregate of pluripotent stem cells

Embryoid bodies (EBs) are three-dimensional aggregates of pluripotent stem cells.

<span class="mw-page-title-main">Hydroxyapatite</span> Naturally occurring mineral form of calcium apatite

Hydroxyapatite is a naturally occurring mineral form of calcium apatite with the formula Ca5(PO4)3(OH), often written Ca10(PO4)6(OH)2 to denote that the crystal unit cell comprises two entities. It is the hydroxyl endmember of the complex apatite group. The OH ion can be replaced by fluoride or chloride, producing fluorapatite or chlorapatite. It crystallizes in the hexagonal crystal system. Pure hydroxyapatite powder is white. Naturally occurring apatites can, however, also have brown, yellow, or green colorations, comparable to the discolorations of dental fluorosis.

<span class="mw-page-title-main">Bioglass 45S5</span> Bioactive glass biomaterial

Bioglass 45S5 or calcium sodium phosphosilicate, is a bioactive glass specifically composed of 45 wt% SiO2, 24.5 wt% CaO, 24.5 wt% Na2O, and 6.0 wt% P2O5. Typical applications of Bioglass 45S5 include: bone grafting biomaterials, repair of periodontal defects, cranial and maxillofacial repair, wound care, blood loss control, stimulation of vascular regeneration, and nerve repair.

<span class="mw-page-title-main">Bioactive glass</span> Surface reactive glass-ceramic biomaterial

Bioactive glasses are a group of surface reactive glass-ceramic biomaterials and include the original bioactive glass, Bioglass. The biocompatibility and bioactivity of these glasses has led them to be used as implant devices in the human body to repair and replace diseased or damaged bones. Most bioactive glasses are silicate-based glasses that are degradable in body fluids and can act as a vehicle for delivering ions beneficial for healing. Bioactive glass is differentiated from other synthetic bone grafting biomaterials, in that it is the only one with anti-infective and angiogenic properties.

<span class="mw-page-title-main">Biomaterial</span> Any substance that has been engineered to interact with biological systems for a medical purpose

A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose, either a therapeutic or a diagnostic one. The corresponding field of study, called biomaterials science or biomaterials engineering, is about fifty years old. It has experienced steady and strong growth over its history, with many companies investing large amounts of money into the development of new products. Biomaterials science encompasses elements of medicine, biology, chemistry, tissue engineering and materials science.

<span class="mw-page-title-main">Thyroid hormone receptor alpha</span> Protein-coding gene in the species Homo sapiens

Thyroid hormone receptor alpha (TR-alpha) also known as nuclear receptor subfamily 1, group A, member 1 (NR1A1), is a nuclear receptor protein that in humans is encoded by the THRA gene.

Amorphous calcium phosphate (ACP) is a glassy solid that is formed from the chemical decomposition of a mixture of dissolved phosphate and calcium salts (e.g. (NH4)2HPO4 + Ca(NO3)2). The resulting amorphous mixture consists mostly of calcium and phosphate, but also contains varying amounts of water and hydrogen and hydroxide ions, depending on the synthesis conditions. Such mixtures are also known as calcium phosphate cement.

<span class="mw-page-title-main">Klaas de Groot</span> Dutch bioengineer (1940–2024)

Klaas de Groot was a Dutch bioengineer. He worked as professor at Leiden University and the University of Twente.

Materiomics is the holistic study of material systems. Materiomics examines links between physicochemical material properties and material characteristics and function. The focus of materiomics is system functionality and behavior, rather than a piecewise collection of properties, a paradigm similar to systems biology. While typically applied to complex biological systems and biomaterials, materiomics is equally applicable to non-biological systems. Materiomics investigates the material properties of natural and synthetic materials by examining fundamental links between processes, structures and properties at multiple scales, from nano to macro, by using systematic experimental, theoretical or computational methods.

<span class="mw-page-title-main">Artificial bone</span> Bone-like material

Artificial bone refers to bone-like material created in a laboratory that can be used in bone grafts, to replace human bone that was lost due to severe fractures, disease, etc.

<span class="mw-page-title-main">Arginylglycylaspartic acid</span> Chemical compound

Arginylglycylaspartic acid (RGD) is the most common peptide motif responsible for cell adhesion to the extracellular matrix (ECM), found in species ranging from Drosophila to humans. Cell adhesion proteins called integrins recognize and bind to this sequence, which is found within many matrix proteins, including fibronectin, fibrinogen, vitronectin, osteopontin, and several other adhesive extracellular matrix proteins. The discovery of RGD and elucidation of how RGD binds to integrins has led to the development of a number of drugs and diagnostics, while the peptide itself is used ubiquitously in bioengineering. Depending on the application and the integrin targeted, RGD can be chemically modified or replaced by a similar peptide which promotes cell adhesion.

<span class="mw-page-title-main">Mineralized tissues</span> Biological tissues incorporating minerals

Mineralized tissues are biological tissues that incorporate minerals into soft matrices. Typically these tissues form a protective shield or structural support. Bone, mollusc shells, deep sea sponge Euplectella species, radiolarians, diatoms, antler bone, tendon, cartilage, tooth enamel and dentin are some examples of mineralized tissues.

<span class="mw-page-title-main">Surface modification of biomaterials with proteins</span>

Biomaterials are materials that are used in contact with biological systems. Biocompatibility and applicability of surface modification with current uses of metallic, polymeric and ceramic biomaterials allow alteration of properties to enhance performance in a biological environment while retaining bulk properties of the desired device.

The in vivo bioreactor is a tissue engineering paradigm that uses bioreactor methodology to grow neotissue in vivo that augments or replaces malfunctioning native tissue. Tissue engineering principles are used to construct a confined, artificial bioreactor space in vivo that hosts a tissue scaffold and key biomolecules necessary for neotissue growth. Said space often requires inoculation with pluripotent or specific stem cells to encourage initial growth, and access to a blood source. A blood source allows for recruitment of stem cells from the body alongside nutrient delivery for continual growth. This delivery of cells and nutrients to the bioreactor eventually results in the formation of a neotissue product. 

<span class="mw-page-title-main">Antonios Mikos</span> Greek-American biomedical engineer

Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.

<span class="mw-page-title-main">Joyce Wong</span> American engineer and professor

Joyce Y. Wong is an American engineer who is Professor of Biomedical Engineering and Materials Science and Engineering at Boston University. Her research develops novel biomaterials for the early detection treatment of disease. Wong is the Inaugural Director of the Provost's Initiative to promote gender equality and inclusion in STEM at all levels: Advance, Recruit, Retain and Organize Women in STEM. She is a Fellow of the American Association for the Advancement of Science, American Institute for Medical and Biological Engineering and Biomedical Engineering Society.

A blastoid is an embryoid, a stem cell-based embryo model which, morphologically and transcriptionally resembles the early, pre-implantation, mammalian conceptus, called the blastocyst. The first blastoids were created by the Nicolas Rivron laboratory by combining mouse embryonic stem cells and mouse trophoblast stem cells. Upon in vitro development, blastoids generate analogs of the primitive endoderm cells, thus comprising analogs of the three founding cell types of the conceptus, and recapitulate aspects of implantation on being introduced into the uterus of a compatible female. Mouse blastoids have not shown the capacity to support the development of a foetus and are thus generally not considered as an embryo but rather as a model. As compared to other stem cell-based embryo models, blastoids model the preimplantation stage and the integrated development of the conceptus including the embryo proper and the two extraembryonic tissues. The blastoid is a model system for the study of mammalian development and disease. It might be useful for the identification of therapeutic targets and preclinical modelling.

Thomas J. Webster is an American biomedical engineer, researcher, and entrepreneur. Throughout his over 25-year academic career, his research group has produced several books and book chapters. He has over 1350 publications and has an H-index of 118. This high H-index places him amongst the top 1% of researchers in his field.

Matthias Lutolf is a bio-engineer and a professor at EPFL where he leads the Laboratory of Stem Cell Bioengineering. He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models. In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.

References

  1. Miron, R.J.; Zhang, Y.F. (August 2012). "Osteoinduction: A Review of Old Concepts with New Standards". Journal of Dental Research. 91 (8): 736–744. doi:10.1177/0022034511435260. ISSN   0022-0345. PMID   22318372. S2CID   209326442.
  2. Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A, Walsh WR, van Blitterswijk CA, de Bruijn JD (August 2010). "Osteoinductive ceramics as a synthetic alternative to autologous bone grafting". Proceedings of the National Academy of Sciences of the United States of America. 107 (31): 13614–9. Bibcode:2010PNAS..10713614Y. doi: 10.1073/pnas.1003600107 . PMC   2922269 . PMID   20643969.
  3. Van Blitterswijk, C. A.; Kuijpers, W.; Daems, W Th; Grote, J. J. (January 1986). "Epithelial Reactions to Hydroxyapatite: An in Vivo and in Vitro Study". Acta Oto-Laryngologica. 101 (3–4): 231–241. doi:10.3109/00016488609132832. ISSN   0001-6489. PMID   3705952.
  4. van Blitterswijk, C.A.; Grote, J.J.; Kuijpers, W.; Daems, W.Th.; de Groot, K. (March 1986). "Macropore tissue ingrowth: a quantitative and qualitative study on hydroxyapatite ceramic". Biomaterials. 7 (2): 137–143. doi:10.1016/0142-9612(86)90071-2. ISSN   0142-9612. PMID   3011138.
  5. 1 2 "ESB European Society for Biomaterials". www.esbiomaterials.eu. Archived from the original on 8 November 2021. Retrieved 1 June 2020.
  6. Nell, M.J.; Op’t Hof, B.M.; Koerten, H.K.; Grote, J.J. (1999). "Effect of Endotoxin on Cultured Human Middle Ear Epithelium". ORL. 61 (4): 201–205. doi:10.1159/000027671. ISSN   0301-1569. PMID   10450054. S2CID   20788406.
  7. Bakker, D.; van Blitterswijk, C. A.; Hesseling, S. C.; Th. Daems, W.; Kuijpers, W.; Grote, J. J. (June 1990). "The behavior of alloplastic tympanic membranes inStaphylococcus aureus-induced middle ear infection. I. Quantitative biocompatibility evaluation". Journal of Biomedical Materials Research. 24 (6): 669–688. doi:10.1002/jbm.820240604. ISSN   0021-9304. PMID   2163404.
  8. Jj, Grote; D, Bakker; Sc, Hesseling; Ca, van Blitterswijk (September 1991). "New Alloplastic Tympanic Membrane Material". The American Journal of Otology. 12 (5): 329–35. PMID   1665011.
  9. van Blitterswijk, C. A.; Hesseling, S. C.; Grote, J. J.; Koerten, H. K.; de Groot, K. (April 1990). "The biocompatibility of hydroxyapatite ceramic: A study of retrieved human middle ear implants". Journal of Biomedical Materials Research. 24 (4): 433–453. doi:10.1002/jbm.820240403. ISSN   0021-9304. PMID   2161412.
  10. Verheyen, C. C. P. M.; De Wijn, J. R.; Van Blitterswijk, C. A.; De Groot, K. (October 1992). "Evaluation of hydroxylapatite/poly(l-lactide) composites: Mechanical behavior". Journal of Biomedical Materials Research. 26 (10): 1277–1296. doi:10.1002/jbm.820261003. ISSN   0021-9304. PMID   1331112.
  11. Unadkat HV, Hulsman M, Cornelissen K, Papenburg BJ, Truckenmüller RK, Carpenter AE, Wessling M, Post GF, Uetz M, Reinders MJ, Stamatialis D, van Blitterswijk CA, de Boer J (October 2011). "An algorithm-based topographical biomaterials library to instruct cell fate". Proceedings of the National Academy of Sciences of the United States of America. 108 (40): 16565–70. Bibcode:2011PNAS..10816565U. doi: 10.1073/pnas.1109861108 . PMC   3189082 . PMID   21949368.
  12. Baker M (November 2011). "Trying out topographies" (PDF). Nature Methods. 8 (11): 900. doi: 10.1038/nmeth.1760 . PMID   22167818. S2CID   5421979.
  13. "LSP van Blitterswijk".
  14. "Distinguished university professors – Research – Maastricht University". maastrichtuniversity.nl. Retrieved 1 February 2018.
  15. "Press release Maastricht University". Maastricht University. 8 April 2016.
  16. Geuens, Thomas; van Blitterswijk, Clemens A.; LaPointe, Vanessa L. S. (30 April 2020). "Overcoming kidney organoid challenges for regenerative medicine". npj Regenerative Medicine. 5 (1): 8. doi: 10.1038/s41536-020-0093-4 . ISSN   2057-3995. PMC   7192889 . PMID   32377381.
  17. Samal, Pinak; Maurer, Philipp; Blitterswijk, Clemens; Truckenmüller, Roman; Giselbrecht, Stefan (29 April 2020). "A New Microengineered Platform for 4D Tracking of Single Cells in a Stem‐Cell‐Based In Vitro Morphogenesis Model". Advanced Materials. 32 (24): 1907966. Bibcode:2020AdM....3207966S. doi: 10.1002/adma.201907966 . ISSN   0935-9648. PMID   32346909.
  18. Kuhnt, Tobias; Marroquín García, Ramiro; Camarero-Espinosa, Sandra; Dias, Aylvin; ten Cate, A. Tessa; van Blitterswijk, Clemens A.; Moroni, Lorenzo; Baker, Matthew B. (2019). "Poly(caprolactone- co -trimethylenecarbonate) urethane acrylate resins for digital light processing of bioresorbable tissue engineering implants". Biomaterials Science. 7 (12): 4984–4989. doi: 10.1039/C9BM01042D . ISSN   2047-4830. PMID   31667486.
  19. Sthijns, Mireille M.J.P.E.; LaPointe, Vanessa L.S.; van Blitterswijk, Clemens A. (1 October 2019). "Building Complex Life Through Self-Organization". Tissue Engineering Part A. 25 (19–20): 1341–1346. doi:10.1089/ten.tea.2019.0208. ISSN   1937-3341. PMC   6784492 . PMID   31411111.
  20. Rademakers, Timo; Horvath, Judith M.; Blitterswijk, Clemens A.; LaPointe, Vanessa L.S. (October 2019). "Oxygen and nutrient delivery in tissue engineering: Approaches to graft vascularization". Journal of Tissue Engineering and Regenerative Medicine. 13 (10): 1815–1829. doi:10.1002/term.2932. ISSN   1932-6254. PMC   6852121 . PMID   31310055.
  21. Ooi, Huey Wen; Mota, Carlos; Ten Cate, A. Tessa; Calore, Andrea; Moroni, Lorenzo; Baker, Matthew B. (25 June 2018). "ThiolEne Alginate Hydrogels as Versatile Bioinks for Bioprinting". Biomacromolecules. 19 (8): 3390–3400. doi:10.1021/acs.biomac.8b00696.s001. PMC   6588269 . PMID   29939754.
  22. "IsoTis Orthobiologics Archives". SeaSpine.
  23. "IsoTis – Integra Merger" . Retrieved 30 September 2018.
  24. "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934" . Retrieved 30 September 2018.
  25. "Professor Clemens van Blitterswijk". Kuros Biosciences. Retrieved 24 May 2020.
  26. Van Blitterswijk, Clemens A.; Thomsen, Peter (2008). Tissue Engineering. Academic. ISBN   978-0123708694.
  27. "ESB European Society for Biomaterials". esbiomaterials.eu. Archived from the original on 8 November 2021. Retrieved 1 February 2018.
  28. "Federaprijs-winnaars – Federa". federa.org.
  29. "News_van Blitterswijk most entrepreneurial scientist in 2012" . Retrieved 1 February 2018.
  30. "TERMIS". Archived from the original on 7 July 2017. Retrieved 1 February 2018.
  31. "Over de prijs". avondwenm.nl.
  32. "ESB European Society for Biomaterials". www.esbiomaterials.eu. Retrieved 15 November 2021.